Xellera Therapeutics Launched Hong Kong’s First Commercial Current Good Manufacturing Practice (cGMP) Facility For Cell & Gene Therapy Products
2021.2.8
Xellera Therapeutics Launched Hong Kong’s First Commercial Current Good Manufacturing Practice (cGMP) Facility For Cell & Gene Therapy Products For Cell and Gene Therapy Products Hong Kong’s first-of-its-kind >8,500 ft² commercial cGMP facilities for cell and...